References
Akyol P, Albayrak M, Maral S, et al. Diffuse large B cell lymphoma progression with skin involvement: a case report. J Tissue Viability 2020; 29(3): 216–7.
Sehn LH, Salles G. Diffuse large B-cell lymphoma. N Engl J Med 2021; 384(9): 842–58.
Tilly H. Diffuse large B-cell lymphoma: ESMO clinical practice guidelines. Ann Oncol 2015; 26: v116–25.
Martelli M, Ferreri AJ, Agostinelli C, et al. Diffuse large B-cell lymphoma. Crit Rev Oncol Hematol 2013; 87: 146–71.
Santucci M, Pimpinelli N. Primary cutaneous B-cell lymphomas. Current concepts. I. Haematologica 2004; 89(11): 1360–71.
Wilcox RA. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management. Am J Hematol 2018; 93(11): 1427–30.
Shamsudin N, Chang CC. Diffuse large B-cell lymphoma presenting with extensive cutaneous infiltration. Singapore Med J 2012; 53(9): e198–200.
Lee WJ, Won KH, Won CH, et al. Secondary cutaneous diffuse large B-cell Lymphoma has a Higher International Prognostic Index Score and worse prognosis than diffuse large B-cell Lymphoma, leg type. Acta Derm Venereol 2016; 96: 245–50.
Zackheim HS, Vonderheid EC, Ramsay DL, LeBoit PE, Rothfleisch J, Kashani-Sabet M. Relative frequency of various forms of primary cutaneous lymphomas. J Am Acad Dermatol 2000; 43(5 Pt 1): 793–6.
Maurer MJ, Ghesquières H, Jais J-P, et al. Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy. J Clin Oncol 2014; 32: 1066–73.
Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 2014; 32: 3059–68.
Author information
Authors and Affiliations
Corresponding author
Additional information
Disclosures
Patient consent: obtained. Conflicts of interest: none.
About this article
Cite this article
Alband, N., Yethenpa, S., McDonald, S. et al. A necrotic groin mass in a patient with systemic diffuse large B-cell lymphoma. Eur J Dermatol 31, 427–429 (2021). https://doi.org/10.1684/ejd.2021.4071
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2021.4071